Skip to main content
≥99.0% HPLC Verified • SEPA Bank & Crypto • Min. Order €220
≥99.0% Lot SL-2026-134
IGF-1 LR3 1 mg — ≥99.0% analytical research vial
≥99.0%
Analytical Purity
24–48h Dispatch
CH/EU Cold-Chain
SL-2026-134
Active Batch Lot
GH Secretagogues & Growth Factors • In stock — Ready to ship

IGF-1 LR3 (1 mg)

€68 1 mg • EUR

IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is an 83-amino acid recombinant IGF-1 analogue featuring an Arg3 substitution and 13-residue N-terminal extension that dramatically reduces IGFBP sequestration in cell-culture proliferation models.

Chemical & Registry Specifications
CAS Registry Number 946870-92-4
Molecular Formula C400H625N111O115S9
Molecular Weight 9111.50 g/mol
Counterion / Form Lyophilized sterile acetate/HCl cake
Sequence / Structural Class 83-aa recombinant human IGF-1 analogue (Glu3→Arg substitution + 13-aa N-terminal extension)
Primary Biological Target / Pathway Insulin-like Growth Factor 1 Receptor (IGF-1R) with reduced IGFBP binding
Cold-chain dispatch: CH 1–2d (Free) • EU 2–4d (€12, Free >€150) Shipping & returns
Min. order €220.00 • Payment via SEPA Bank Transfer (EUR) (request IBAN via LiveChat/email) or Crypto (BTC, ETH, USDT, USDC, SOL, XMR).

Scientific Profile & Research Key Points: IGF-1 LR3

IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is an 83-amino acid recombinant IGF-1 analogue featuring an Arg3 substitution and 13-residue N-terminal extension that dramatically reduces IGFBP sequestration in cell-culture proliferation models.

83-residue LR3 structure confirmed via LC-MS (9111.5 Da)
Low IGFBP affinity enables sustained IGF-1R signaling
Requires 0.6% Acetic Acid reconstitution for full recovery
Primary Literature Reference Francis G.L. et al., J Mol Endocrinol (1992) — LR3-IGF-1 reduced IGFBP affinity and enhanced cellular potency (PMID: 1378283)
View on PubMed ↗

Active Batch Release Specifications (Lot SL-2026-134)

Analytical release verification for current IGF-1 LR3 (1 mg) inventory

Open Full Batch Registry
Batch Lot # Release Date Analytical Method Purity Spec Endotoxin (LAL) Moisture
SL-2026-134 2026-10-28 SEC-HPLC + SDS-PAGE (Reducing & Non-Reducing) ≥99.0% (Monomeric Purity) <0.5 EU/mg <2.8% (Karl Fischer)

Laboratory Solubilization & Storage Protocol

Recommended Solvent / Handling

Pre-dissolve in sterile 0.6% (10 mM) Acetic Acid (0.5–1.0 mL), then dilute with buffered carrier solution

Temperature & Stability

Store lyophilized at -20°C; store acidic stock aliquots at -20°C or 2°C–8°C (avoid neutral water alone).

IGF-1 LR3 — Technical Questions & Answers

Why is IGF-1 LR3 analyzed by SEC-HPLC and SDS-PAGE instead of standard small-peptide RP-HPLC alone?

At 9111.50 g/mol, recombinant proteins like IGF-1 LR3 possess tertiary and quaternary folding structures that denature under harsh reversed-phase organic gradients. Size-exclusion chromatography (SEC-HPLC) and SDS-PAGE verify monomeric integrity and detect dimers or aggregates.

How do researchers minimize adsorption and aggregation when preparing IGF-1 LR3 (1 mg)?

Avoid vigorous vortexing, foaming, or repeated freeze-thaw cycles. Slowly introduce buffer along the borosilicate vial wall and consider low-protein-binding polypropylene tubes (or carrier protein buffer where assay-compatible) for nanomolar working dilutions.

What biological receptor system is IGF-1 LR3 used to probe in vitro?

IGF-1 LR3 (CAS 946870-92-4) targets Insulin-like Growth Factor 1 Receptor (IGF-1R) with reduced IGFBP binding (Lyophilized sterile acetate/HCl cake). Reference publication: Francis G.L. et al., J Mol Endocrinol (1992) — LR3-IGF-1 reduced IGFBP affinity and enhanced cellular potency (PMID: 1378283).

Research Use Only (RUO): IGF-1 LR3 is supplied strictly for laboratory in-vitro experimentation and analytical investigation by qualified personnel. Not for human or veterinary administration.

Related Scientific Monographs

Peer-reviewed mechanism summaries and analytical protocols

All monographs (44)

Related GH Secretagogues & Growth Factors Compounds

View category →
≥99.0%
ACE-031 1 mg — ≥99.0% Research Vial
ACE-031
1 mg In stock
CAS 1169766-01-1
MW: ~79.0 kDa (homodimer)
€75
≥99.0%
CJC-1295 5 mg — ≥99.0% Research Vial
CJC-1295
5 mg In stock
CAS 863288-34-0 (with DAC)
MW: 3647.28 g/mol
€48
≥99.0%
CJC-1295 + Ipamorelin 5mg + 5mg — ≥99.0% Research Vial
CJC-1295 + Ipamorelin
5mg + 5mg In stock
CAS 863288-34-0 / 170851-70-4
MW: 3367.97 g/mol & 711.86 g/mol
€62

Your Research Cart

0 items selected • Min. order €220

SEPA Bank Transfer & Crypto (BTC, ETH, USDT, USDC, SOL, XMR)
Min €220

Your cart is empty

Browse our catalog of research peptides and reagents (minimum order €220).

Browse Catalog